How to buy Cronos shares | CRON historical share price and analysis

How to buy Cronos shares

Own Cronos shares in just a few minutes.

Updated

Fact checked

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Cronos Group Inc is a drug manufacturers-specialty & generic business with stocks listed in the US. Cronos shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars. Here's how to invest if you're based in Australia.

How to buy shares in Cronos

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cronos. Find the share by name or ticker symbol: CRON. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Cronos, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Cronos. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

Cronos share price

Use our graph to track the performance of CRON stocks over time.

Cronos shares at a glance

Information last updated 2021-03-03.
52-week rangeUS$4 - US$15.83
50-day moving average US$11.4579
200-day moving average US$7.7071
Target priceN/A
PE ratio 37.0035
Dividend yield N/A (0%)
Earnings per share (TTM) US$0.287

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro Share Trading (US stocks)
USD 0
USD 10 per month if there’s been no login for 12 months
0.50%
Forex, CFDs, US shares
Zero brokerage share trading on US stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and forex from the one account.
CMC Markets Stockbroking
USD 0
No
0.60%
ASX shares, Global shares, Forex, CFDs, Options trading, mFunds, ETFs, Warrants
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
IG Share Trading
Finder Award
IG Share Trading
USD 0
AUD 50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares, Forex, CFDs, Margin trading
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Note: $10,000 deposit required to open account.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
USD 9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading
High quality, low-cost brokerage on global share trading.
Access up to 19,000 global stocks on 36 of the world’s major stock exchanges and enjoy some of the most competitive FX rates on the the market when you trade with Saxo Capital Markets.
loading

Compare up to 4 providers

Is it a good time to buy Cronos stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is Cronos under- or over-valued?

Valuing Cronos stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cronos's P/E ratio

Cronos's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Cronos shares trade at around 37x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Cronos financials

Revenue TTM US$37 million
Gross profit TTM US$-17,864,000
Return on assets TTM -5.78%
Return on equity TTM 5.82%
Profit margin 270.68%
Book value 4.967
Market capitalisation US$3.8 billion

TTM: trailing 12 months

Shorting Cronos shares

There are currently 25.9 million Cronos shares held short by investors – that's known as Cronos's "short interest". This figure is 0.6% down from 26.1 million last month.

There are a few different ways that this level of interest in shorting Cronos shares can be evaluated.

Cronos's "short interest ratio" (SIR)

Cronos's "short interest ratio" (SIR) is the quantity of Cronos shares currently shorted divided by the average quantity of Cronos shares traded daily (recently around 9.0 million). Cronos's SIR currently stands at 2.87. In other words for every 100,000 Cronos shares traded daily on the market, roughly 2870 shares are currently held short.

However Cronos's short interest can also be evaluated against the total number of Cronos shares, or, against the total number of tradable Cronos shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Cronos shares in existence, roughly 70 shares are currently held short) or 0.1387% of the tradable shares (for every 100,000 tradable Cronos shares, roughly 139 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cronos.

Find out more about how you can short Cronos stock.

Cronos share dividends

We're not expecting Cronos to pay a dividend over the next 12 months.

Cronos share price volatility

Over the last 12 months, Cronos's shares have ranged in value from as little as US$4 up to US$15.83. A popular way to gauge a stock's volatility is its "beta".

CRON.US volatility(beta: 1.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos's is 1.9902. This would suggest that Cronos's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cronos overview

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site